Skip to Main Content

Paper Details

Retained functional normal and preleukemic HSCs at diagnosis are associated with good prognosis in DNMT3AmutNPM1mut AMLs.
Blood Adv
3
2023
AML, AMLs, CD34, CD34+, CD34+ subpopulations, CD34+CD38- cells, CD34-, CD34- LSCs, CD34- and CD34+ LSCs, CD34-GPR56+NKG2DL- enriched LSCs, CD34neg, CD34neg AML subtypes, CD38, DNMT3Amut, DNMT3AmutNPM1mut, DNMT3AmutNPM1mut AML samples, GPR56, HSCs, LSCs, Leukemic, Leukemic Stem Cells, NKG2D-Ligands, NKG2DL, NPM1mut, blasts, mice, normal and, normal and/or pre-leukemic Hematopoietic Stem Cells, patients, preleukemic HSCs
Author NameAffiliation
Christoph R??lligUniversity Hospital Carl Gustav Carus, Technische Universitat (TU) Dresden
Frank BuchholzUniversity Hospital Carl Gustav Carus, Technische Universitat (TU) Dresden
Frank BuchholzNational Center for Tumor Diseases (NCT/UCC)
Frank BuchholzGerman Cancer Research Center (DKFZ)
Frank BuchholzPartner Site Dresden and German Cancer Research Center (DKFZ)
Frank BuchholzFaculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitat Dresden
Frank Buchholz
Daniel H??bschmannGerman Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance
Daniel H??bschmannHeidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH)
Daniel H??bschmann
Daniel H??bschmannGerman Cancer Research Center/ National Center for Tumor Diseases Heidelberg (NCT)
Daniel H??bschmannGerman Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance
Daniel H??bschmannHeidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH)
Daniel H??bschmann
Daniel H??bschmannGerman Cancer Research Center/ National Center for Tumor Diseases Heidelberg (NCT)
  • 1 - 15

Datasets

Release 1.2